In December 2019 SARS-CoV-2 initiated a worldwide COVID-19 pandemic, which is still ongoing in 2022. Although adult elderly patients with chronic preexisting diseases had been identified as the most vulnerable group, COVID-19 has also had a significant impact on pediatric intensive care. Early in 2020, a new disease presentation, multisystemic inflammatory syndrome, was described in children. Despite the vaccination that is available for all age categories, due to its selection process, new viral mutations and highly variable vaccination rate, COVID-19 remains a significant clinical challenge in adult and pediatric intensive care in 2022.

Department of Anaesthesiology and Intensive Care Medicine The Donaustadt Clinic Lango Bardenstraße 122 1220 Vienna Austria

Department of Paediatric Anaesthesiology and Intensive Care Medicine University Hospital Brno and Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Department of Simulation Medicine Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Zobrazit více v PubMed

Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Features, Evaluation, and Treatment of Coronavirus (COVID-19) PubMed

Kache S., Chisti M.J., Gumbo F., Mupere E., Zhi X., Nallasamy K., Nakagawa S., Lee J.H., Di Nardo M., de la Oliva P., et al. COVID-19 PICU guidelines: For high-and limited-resource settings. Pediatr. Res. 2020;88:705–716. doi: 10.1038/s41390-020-1053-9. PubMed DOI PMC

World Health Organization Coronavirus Disease 2019 (COVID-19): Situation Report. [(accessed on 5 February 2022)]. Available online: http://www.Who.Int/docs/default-source/coronaviruse/situation-reports.2.

Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–1608. doi: 10.1016/S0140-6736(20)31094-1. PubMed DOI PMC

Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141–154. doi: 10.1038/s41579-020-00459-7. PubMed DOI PMC

Abdelghany T.M., Ganash M., Bakri M.M., Qanash H., Al-Rajhi A.M.H., Elhussieny N.I. SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions. Biomed. J. 2021;44:86–93. doi: 10.1016/j.bj.2020.10.008. PubMed DOI PMC

Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8:475–481. doi: 10.1016/S2213-2600(20)30079-5. PubMed DOI PMC

Fernández-Sarmiento J., De Souza D., Jabornisky R., Gonzalez G.A., Arias López M.D.P., Palacio G. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): A narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee. BMJ Paediatr. Open. 2021;5:e000894. doi: 10.1136/bmjpo-2020-000894. PubMed DOI PMC

Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., et al. Genomic haracterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. PubMed DOI PMC

Carlotti A.P.C.P., Carvalho W.B., Johnston C., Rodriguez I.S., Delgado A.F. COVID-19 Diagnostic and Management Protocol for Pediatric Patients. Clinics. 2020;75:e1894. doi: 10.6061/clinics/2020/e1894. PubMed DOI PMC

Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7. PubMed DOI PMC

Li S.R., Tang Z.J., Li Z.H., Liu X. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: The target of COVID-19 and SARS-CoV. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:1021–1026. doi: 10.1007/s10096-020-03883-y. PubMed DOI PMC

Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. PubMed DOI PMC

Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. HLH Across Speciality Collaboration, UK. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0. PubMed DOI PMC

Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934–943. doi: 10.1001/jamainternmed.2020.0994. PubMed DOI PMC

World Health Organization Tracking SARS-CoV-2 Variants. [(accessed on 5 February 2022)]. Available online: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

Stokes E.K., Zambrano L.D., Anderson K.N., Marder E.P., Raz K.M., El Burai Felix S., Tie Y., Fullerton K.E. Coronavirus Disease 2019 Case Surveillance–United States. MMWR Morb. Mortal Wkly. Rep. 2020;69:759–765. doi: 10.15585/mmwr.mm6924e2. PubMed DOI PMC

Marek S., Chrdle A., Husa P., Beneš J., Dlouhy P., Infekce.cz COVID-19 Diagnostika a Léčba. [(accessed on 5 February 2022)]. Available online: https://www.infekce.cz/DPCovid21/DP5-covid-DP-podrobny-09-21.pdf.

Chen Z.M., Fu J.F., Shu Q., Chen Y.H., Hua C.Z., Li F.B., Lin R., Tang L.F., Wang T.L., Wang W., et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J. Pediatr. 2020;16:240–246. doi: 10.1007/s12519-020-00345-5. PubMed DOI PMC

Poline J., Gaschignard J., Leblanc C., Madhi F., Foucaud E., Nattes E., Faye A., Bonacorsi S., Mariani P., Varon E., et al. Systematic Severe Acute Respiratory Syndrome Coronavirus 2 Screening at Hospital Admission in Children: A French Prospective Multicenter Study. Clin. Infect. Dis. 2021;72:2215–2217. doi: 10.1093/cid/ciaa1044. PubMed DOI PMC

Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145:e20200702. doi: 10.1542/peds.2020-0702. PubMed DOI

Ogimi C., Englund J.A., Bradford M.C., Qin X., Boeckh M., Waghmare A. Characteristics and Outcomes of Coronavirus Infection in Children: The Role of Viral Factors and an Immunocompromised State. J. Pediatr. Infect. Dis. Soc. 2019;8:21–28. doi: 10.1093/jpids/pix093. PubMed DOI PMC

Morand A., Fabre A., Minodier P., Boutin A., Vanel N., Bosdure E., Fournier P.E. COVID-19 virus and children: What do we know? Arch. Pediatr. 2020;27:117–118. doi: 10.1016/j.arcped.2020.03.001. PubMed DOI PMC

Balasubramanian S., Rao N.M., Goenka A., Roderick M., Ramanan A.V. Coronavirus Disease 2019 (COVID-19) in Children-What We Know So Far and What We Do Not. Indian Pediatr. 2020;57:435–442. doi: 10.1007/s13312-020-1819-5. PubMed DOI PMC

Royal College of Pediatrics and Child Health Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19. [(accessed on 5 February 2022)]. Available online: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf.

Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19) [(accessed on 5 February 2022)]; Available online: https://emergency.cdc.gov/han/2020/han00432.asp.

European Centre for Disease Control and Prevention Paediatric Inflammatory Multisystem Syndrome and SARS-CoV-2 Infection in Children. [(accessed on 5 February 2022)]. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-risk-assessment-paediatric-inflammatory-multisystemsyndrome-15-May-2020.pdf.

Rimensberger P.C., Kneyber M.C.J., Deep A., Bansal M., Hoskote A., Javouhey E., Jourdain G., Latten L., MacLaren G., Morin L., et al. European Society of Pediatric and Neonatal Intensive Care (ESPNIC) Scientific Sections’ Collaborative Group. Caring for Critically Ill Children with Suspected or Proven Coronavirus Disease 2019 Infection: Recommendations by the Scientific Sections’ Collaborative of the European Society of Pediatric and Neonatal Intensive Care. Pediatr. Crit. Care Med. 2021;22:56–67. doi: 10.1097/PCC.0000000000002599. PubMed DOI PMC

Whittaker E., Bamford A., Kenny J., Kaforou M., Jones E., Shah P., Ramnarayan P., Fraisse E., Miller O., Davies P., et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020;324:259–269. doi: 10.1001/jama.2020.10369. PubMed DOI PMC

Belot A., Antona D., Renolleau S., Javouhey E., Hentgen V., Angoulvant F., Delacourt C., Iriart X., Ovaert C., Bader-Meunier B., et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. 2020;25:2001010. doi: 10.2807/1560-7917.ES.2020.25.22.2001010. PubMed DOI PMC

Swann O.V., Holden K.A., Turtle L., Pollock L., Fairfield C.J., Drake T.M., Seth S., Egan C., Hardwick H.E., Halpin S., et al. ISARIC4C Investigators. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: Prospective multicentre observational cohort study. BMJ. 2020;370:m3249. doi: 10.1136/bmj.m3249. PubMed DOI PMC

Götzinger F., Santiago-García B., Noguera-Julián A., Lanaspa M., Lancella L., Calò Carducci F.I., Gabrovska N., Velizarova S., Prunk P., Osterman V., et al. COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study. Lancet Child. Adolesc. Health. 2020;4:653–661. doi: 10.1016/S2352-4642(20)30177-2. PubMed DOI PMC

Fraile Navarro D., Tendal B., Tingay D., Vasilunas N., Anderson L., Best J., Burns P., Cheyne S., Craig S.S., Erickson S.J., et al. Clinical care of children and adolescents with COVID-19: Recommendations from the National COVID-19 Clinical Evidence Taskforce. Med. J. Aust. 2021 doi: 10.5694/mja2.51305. PubMed DOI PMC

Shekerdemian L.S., Mahmood N.R., Wolfe K.K., Riggs B.J., Ross C.E., McKiernan C.A., Heidemann S.M., Kleinman L.C., Sen A.I., Hall M.W., et al. Characteristics and Outcomes of Children with Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. 2020;174:868–873. doi: 10.1001/jamapediatrics.2020.1948. PubMed DOI PMC

Bixler D., Miller A.D., Mattison C.P., Taylor B., Komatsu K., Peterson Pompa X., Moon S., Karmarkar E., Liu C.Y., Openshaw J., et al. SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years–United States. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1324–1329. doi: 10.15585/mmwr.mm6937e4. PubMed DOI

González-Dambrauskas S., Vásquez-Hoyos P., Camporesi A., Díaz-Rubio F., Piñeres-Olave B.E., Fernández-Sarmiento J., Gertz S., Harwayne-Gidansky I., Pietroboni P., Shein S.L., et al. Critical coronavirus and kids epidemiology cake study. Pediatric Critical Care and COVID-19. Pediatrics. 2020;146:e20201766. doi: 10.1542/peds.2020-1766. PubMed DOI

Bouadma L., Lescure F.X., Lucet J.C., Yazdanpanah Y., Timsit J.F. Severe SARS-CoV-2 infections: Practical considerations and management strategy for intensivists. Intensive Care Med. 2020;46:579–582. doi: 10.1007/s00134-020-05967-x. PubMed DOI PMC

National Institutes of Health COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. [(accessed on 5 February 2022)]; Available online: https://www.covid19treatmentguidelines.nih.gov/ PubMed

Kucirka L.M., Lauer S.A., Laeyendecker O., Boon D., Lessler J. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann. Intern. Med. 2020;173:262–267. doi: 10.7326/M20-1495. PubMed DOI PMC

Jackson K., Butler R., Aujayeb A. Lung ultrasound in the COVID-19 pandemic. Postgrad. Med. J. 2021;97:34–39. doi: 10.1136/postgradmedj-2020-138137. PubMed DOI PMC

Van de Voorde P., Turner N.M., Djakow J., de Lucas N., Martinez-Mejias A., Biarent D., Bingham R., Brissaud O., Hoffmann F., Johannesdottir G.B., et al. European Resuscitation Council Guidelines 2021: Paediatric Life Support. Resuscitation. 2021;161:327–387. doi: 10.1016/j.resuscitation.2021.02.015. PubMed DOI

Klučka J., Klabusayová E., Musilová T., Kramplová T., Skříšovská T., Kratochvíl M., Kosinová M., Horák O., Ošlejšková H., Jabandžiev P., et al. Pediatric Patient with Ischemic Stroke: Initial Approach and Early Management. Children. 2021;8:649. doi: 10.3390/children8080649. PubMed DOI PMC

Matava C.T., Kovatsis P.G., Lee J.K., Castro P., Denning S., Yu J., Park R., Lockman J.L., Von Ungern-Sternberg B., Sabato S., et al. Pediatric Airway Management in COVID-19 Patients: Consensus Guidelines from the Society for Pediatric Anesthesia’s Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society. Anesth. Analg. 2020;131:61–73. doi: 10.1213/ANE.0000000000004872. PubMed DOI PMC

Pediatric Acute Lung Injury Consensus Conference Group Pediatric acute respiratory distress syndrome: Consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference. Pediatr. Crit. Care Med. 2015;16:428–439. doi: 10.1097/PCC.0000000000000350. PubMed DOI PMC

Weiss S.L., Peters M.J., Alhazzani W., Agus M.S.D., Flori H.R., Inwald D.P., Nadel S., Schlapbach L.J., Tasker R.C., Argent A.C., et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46:10–67. doi: 10.1007/s00134-019-05878-6. PubMed DOI PMC

Davis A.L., Carcillo J.A., Aneja R.K., Deymann A.J., Lin J.C., Nguyen T.C., Okhuysen-Cawley R.S., Relvas M.S., Rozenfeld R.A., Skippen P.W., et al. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit. Care Med. 2017;45:1061–1093. doi: 10.1097/CCM.0000000000002425. PubMed DOI

Harris J., Ramelet A.S., van Dijk M., Pokorna P., Wielenga J., Tume L., Tibboel D., Ista E. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: An ESPNIC position statement for healthcare professionals. Intensive Care Med. 2016;42:972–986. doi: 10.1007/s00134-016-4344-1. PubMed DOI PMC

Walker T., Kudchadkar S.R. Pain and Sedation Management: 2018 Update for the Rogers’ Textbook of Pediatric Intensive Care. Pediatr. Crit. Care Med. 2019;20:54–61. doi: 10.1097/PCC.0000000000001765. PubMed DOI

Food and Drug Administration Fact Sheet for Healthcare Providers: Emergency Use Authorization (EUA) of Veklury (Remdesivir) for Hospitalized Pediatric Patients Weighing 3.5 kg to Less Than 40 kg or Hospitalized Pediatric Patients Less Than 12 Years of Age Weighing at Least 3.5 kg. [(accessed on 5 February 2022)]; Available online: https://www.fda.gov/media/137566/download.

Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., Elmahi E., et al. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436. PubMed DOI PMC

Gordon A.C., Mouncey P.R., Al-Beidh F., Rowan K.M., Nichol A.D., Arabi Y.M., Annane D., Beane A., van Bentum-Puijk W., Berry L.R., et al. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N. Engl. J. Med. 2021;384:1491–1502. doi: 10.1056/NEJMoa2100433. PubMed DOI PMC

Henderson L.A., Canna S.W., Friedman K.G., Gorelik M., Lapidus S.K., Bassiri H., Behrens E.M., Ferris A., Kernan K.F., Schulert G.S., et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2. Arthritis Rheumatol. 2021;73:e13–e29. doi: 10.1002/art.41616. PubMed DOI PMC

Hoang A., Chorath K., Moreira A., Evans M., Burmeister-Morton F., Burmeister F., Naqvi R., Petershack M., Moreira A. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020;24:100433. doi: 10.1016/j.eclinm.2020.100433. PubMed DOI PMC

Tan W., Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int. J. Cardiol. 2020;309:70–77. doi: 10.1016/j.ijcard.2020.03.063. PubMed DOI PMC

Cheung E.W., Zachariah P., Gorelik M., Boneparth A., Kernie S.G., Orange J.S., Milner J.D. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. JAMA. 2020;324:294–296. doi: 10.1001/jama.2020.10374. PubMed DOI PMC

Harwood R., Allin B., Jones C.E., Whittaker E., Ramnarayan P., Ramanan A.V., Kaleem M., Tulloh R., Peters M.J., Almond S., et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): Results of a national Delphi process. Lancet Child. Adolesc Health. 2021;5:133–141. doi: 10.1016/S2352-4642(20)30304-7. PubMed DOI PMC

Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 2020;383:334–346. doi: 10.1056/NEJMoa2021680. PubMed DOI PMC

Dufort E.M., Koumans E.H., Chow E.J., Rosenthal E.M., Muse A., Rowlands J., Barranco M.A., Maxted A.M., Rosenberg E.S., Easton D., et al. Multisystem Inflammatory Syndrome in Children in New York State. N. Engl. J. Med. 2020;383:347–358. doi: 10.1056/NEJMoa2021756. PubMed DOI PMC

Godfred-Cato S., Bryant B., Leung J., Oster M.E., Conklin L., Abrams J., Roguski K., Wallace B., Prezzato E., Koumans E.H., et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children-United States, March-July 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1074–1080. doi: 10.15585/mmwr.mm6932e2. PubMed DOI PMC

Kam Y.W., Kien F., Roberts A., Cheung Y.C., Lamirande E.W., Vogel L., Chu S.L., Tse J., Guarner J., Zaki S.R., et al. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. Vaccine. 2007;25:729–740. doi: 10.1016/j.vaccine.2006.08.011. PubMed DOI PMC

Wang S.F., Tseng S.P., Yen C.H., Yang J.Y., Tsao C.H., Shen C.W., Chen K.H., Liu F.T., Liu W.T., Chen Y.M., et al. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochem. Biophys. Res. Commun. 2014;451:208–214. doi: 10.1016/j.bbrc.2014.07.090. PubMed DOI PMC

Morris S.B., Schwartz N.G., Patel P., Abbo L., Beauchamps L., Balan S., Lee E.H., Paneth-Pollak R., Geevarughese A., Lash M.K., et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection-United Kingdom and United States, March-August 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1450–1456. doi: 10.15585/mmwr.mm6940e1. PubMed DOI PMC

Carlin R.F., Fischer A.M., Pitkowsky Z., Abel D., Sewell T.B., Landau E.G., Caddle S., Robbins-Milne L., Boneparth A., Milner J.D., et al. Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings. J. Pediatr. 2021;229:26–32. doi: 10.1016/j.jpeds.2020.10.013. PubMed DOI PMC

McCrindle B.W., Rowley A.H., Newburger J.W., Burns J.C., Bolger A.F., Gewitz M., Baker A.L., Jackson M.A., Takahashi M., Shah P.B., et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017;135:e927–e999. doi: 10.1161/CIR.0000000000000484. PubMed DOI

Ouldali N., Toubiana J., Antona D., Javouhey E., Madhi F., Lorrot M., Léger P.L., Galeotti C., Claude C., Wiedemann A., et al. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone with Course of Fever in Multisystem Inflammatory Syndrome in Children. JAMA. 2021;325:855–864. doi: 10.1001/jama.2021.0694. PubMed DOI PMC

Cattalini M., Taddio A., Bracaglia C., Cimaz R., Paolera S.D., Filocamo G., La Torre F., Lattanzi B., Marchesi A., Simonini G., et al. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): A diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics. Ital. J. Pediatr. 2021;47:24. doi: 10.1186/s13052-021-00980-2. PubMed DOI PMC

Wardle A.J., Connolly G.M., Seager M.J., Tulloh R.M. Corticosteroids for the treatment of Kawasaki disease in children. Cochrane Database Syst. Rev. 2017;1:CD011188. doi: 10.1002/14651858.CD011188.pub2. PubMed DOI PMC

Belhadjer Z., Méot M., Bajolle F., Khraiche D., Legendre A., Abakka S., Auriau J., Grimaud M., Oualha M., Beghetti M., et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation. 2020;142:429–436. doi: 10.1161/CIRCULATIONAHA.120.048360. PubMed DOI

Bansal N., Azeka E., Neunert C., Kim J.S., Murray J., May L., Kirk C., Lorts A., Rosenthal D., VanderPluym C. Multisystem Inflammatory Syndrome Associated with COVID-19 Anti-thrombosis Guideline of Care for Children by Action. Pediatr. Cardiol. 2021;42:1635–1639. doi: 10.1007/s00246-021-02651-9. PubMed DOI PMC

Prata-Barbosa A., Lima-Setta F., Santos G.R.D., Lanziotti V.S., de Castro R.E.V., de Souza D.C., Raymundo C.E., de Oliveira F.R.C., de Lima L.F.P., Tonial C.T., et al. Pediatric patients with COVID-19 admitted to intensive care units in Brazil: A prospective multicenter study. J. Pediatr. 2020;96:582–592. doi: 10.1016/j.jped.2020.07.002. PubMed DOI PMC

Kompaniyets L., Agathis N.T., Nelson J.M., Preston L.E., Ko J.Y., Belay B., Pennington A.F., Danielson M.L., DeSisto C.L., Chevinsky J.R., et al. Underlying Medical Conditions Associated with Severe COVID-19 Illness Among Children. JAMA Netw. Open. 2021;4:e2111182. doi: 10.1001/jamanetworkopen.2021.11182. PubMed DOI PMC

Bailey L.C., Razzaghi H., Burrows E.K., Bunnell H.T., Camacho P.E.F., Christakis D.A., Eckrich D., Kitzmiller M., Lin S.M., Magnusen B.C., et al. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatr. 2021;175:176–184. doi: 10.1001/jamapediatrics.2020.5052. PubMed DOI PMC

Martin B., DeWitt P.E., Russell S., Anand A., Bradwell K.R., Bremer C., Gabriel D., Girvin A.T., Hajagos J.G., McMurry J.A., et al. Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C) medRxiv Prepr. 2021 doi: 10.1101/2021.07.19.21260767. DOI

COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT)

Causes of Intensive Care Unit Admissions in Children with SARS-CoV-2: A Single-Centre Observational Study

Paediatric Deep Neck Infection-The Risk of Needing Intensive Care